These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2206032

  • 41. Diabetic dyslipidemia.
    Kreisberg RA.
    Am J Cardiol; 1998 Dec 17; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Gemfibrozil-lovastatin therapy for primary hyperlipoproteinemias.
    Glueck CJ, Oakes N, Speirs J, Tracy T, Lang J.
    Am J Cardiol; 1992 Jul 01; 70(1):1-9. PubMed ID: 1615846
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
    Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, Tobert JA, Laskarzewski PM, Quiter E, Held J.
    N Engl J Med; 1993 Apr 29; 328(17):1213-9. PubMed ID: 8464431
    [Abstract] [Full Text] [Related]

  • 46. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus.
    Garg A, Grundy SM.
    N Engl J Med; 1988 Jan 14; 318(2):81-6. PubMed ID: 3422105
    [Abstract] [Full Text] [Related]

  • 47. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991 Jan 14; 4(5):285-97. PubMed ID: 1746296
    [Abstract] [Full Text] [Related]

  • 48. Management of primary mixed hyperlipidemia with lovastatin.
    Vega GL, Grundy SM.
    Arch Intern Med; 1990 Jun 14; 150(6):1313-9. PubMed ID: 2353864
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study.
    Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH.
    Diabetes Care; 1992 Jul 14; 15(7):820-5. PubMed ID: 1516498
    [Abstract] [Full Text] [Related]

  • 51. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
    Am J Cardiol; 1990 Sep 18; 66(8):22B-30B. PubMed ID: 2206033
    [Abstract] [Full Text] [Related]

  • 52. Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol. A multicenter study. The Simvastatin Study Group.
    Tikkanen MJ, Bocanegra TS, Walker JF, Cook T.
    Am J Med; 1989 Oct 16; 87(4A):47S-53S. PubMed ID: 2679084
    [Abstract] [Full Text] [Related]

  • 53. Treatment of hypercholesterolemia in NIDDM with policosanol.
    Torres O, Agramonte AJ, Illnait J, Más Ferreiro R, Fernández L, Fernández JC.
    Diabetes Care; 1995 Mar 16; 18(3):393-7. PubMed ID: 7555484
    [Abstract] [Full Text] [Related]

  • 54. Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V.
    Biesenbach G, Zazgornik J.
    Clin Nephrol; 1992 Jun 16; 37(6):274-9. PubMed ID: 1638777
    [Abstract] [Full Text] [Related]

  • 55. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients].
    Zanella MT, Plavinik F, Zampieri M, Peres RB, Ribeiro AB.
    Arq Bras Cardiol; 1993 Jul 16; 61(1):27-31. PubMed ID: 8285861
    [Abstract] [Full Text] [Related]

  • 56. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
    Vázquez M, Zambón D, Hernández Y, Adzet T, Merlos M, Ros E, Laguna JC.
    Br J Clin Pharmacol; 1998 Mar 16; 45(3):265-9. PubMed ID: 9517370
    [Abstract] [Full Text] [Related]

  • 57. A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
    Schweitzer M, Tessier D, Vlahos WD, Leiter L, Collet JP, McQueen MJ, Harvey L, Alaupovic P.
    Atherosclerosis; 2002 May 16; 162(1):201-10. PubMed ID: 11947915
    [Abstract] [Full Text] [Related]

  • 58. Effects of gemfibrozil on triglyceride levels in patients with NIDDM. Hyperlipidemia in Diabetes Investigators.
    Vinik AI, Colwell JA.
    Diabetes Care; 1993 Jan 16; 16(1):37-44. PubMed ID: 8422814
    [Abstract] [Full Text] [Related]

  • 59. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.
    Shear CL, Franklin FA, Stinnett S, Hurley DP, Bradford RH, Chremos AN, Nash DT, Langendorfer A.
    Circulation; 1992 Apr 16; 85(4):1293-303. PubMed ID: 1555273
    [Abstract] [Full Text] [Related]

  • 60. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N, Ramires JA.
    Arq Bras Cardiol; 1991 Sep 16; 57(3):253-61. PubMed ID: 1824203
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.